Why is Astrazeneca Phar falling/rising?

As of 24-Jul, Astrazeneca Pharma India Ltd's stock price is rising, currently at 9,028.85, reflecting an increase of 75.5 (0.84%). The stock has shown a trend reversal, gaining after two consecutive days of decline. Despite a recent drop in delivery volume by 20.68% against the 5-day average, the stock outperformed its sector by 0.49% today. Over the past month, Astrazeneca has delivered a return of 3.22%, significantly outperforming the Sensex, which only increased by 0.16%. The company has demonstrated strong financial performance, with a net profit growth of 88.82% and positive results for the last two quarters, contributing to its high management efficiency and favorable ratings among peers.
In the broader market context, Astrazeneca's recent performance contrasts with the Sensex's slight decline of 0.09% over the past week, indicating that the stock is gaining traction despite a generally flat market. While the stock has shown consistent returns over the past three years, it faces risks such as a high valuation and falling participation from institutional investors, which could impact future growth. Nonetheless, the strong recent financial results and positive market sentiment appear to be driving the stock's upward movement.